Navigation Links
MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology
Date:2/20/2008

Company's Practice-Proven Solution Unanimously Selected to Replace Existing

Vendor System

BOSTON, Feb. 20 /PRNewswire/ -- MedAptus(R), the leading provider of point-of-care charge capture technologies, today announced that Kentucky Medical Services Foundation (KMSF) has selected the MedAptus Professional Charge Capture solution for its clinician base of more than 600 providers.

MedAptus' Professional Charge Capture supports compliant and streamlined coding at the point-of-care. The solution is seamlessly integrated with numerous scheduling, billing, registration and electronic medical records systems and can be deployed via handheld devices, cell phone PDAs, Tablet PCs and workstations. The system has processed millions of charges since its first-generation release in 2001 and has been repeatedly demonstrated to drive rapid and significant revenue increases.

KMSF is the faculty practice plan for the highly regarded University of Kentucky Medical Center and the College of Medicine. In this role the organization provides billing and other administrative services to the multitude of affiliated providers who deliver care across over 80 clinical areas. While KMSF initially adopted mobile charge capture several years ago, the group recently decided that its incumbent solution would no longer meet the needs of its IT strategic initiatives. These concerns led KMSF to assess the vendor and solution market via a formal RFP process and thorough reference checks.

Upon concluding a very methodical landscape review, KMSF chose MedAptus' Professional Charge Capture. The decision, unanimous across the multi-disciplinary steering committee, was largely based on MedAptus' track record of successful implementations and widespread clinician adoption at academic institutions such as Lahey Clinic Medical Center and The University of Texas M. D. Anderson Cancer Center. Members of the KMSF committee witnessed usage of the solu
'/>"/>

SOURCE MedAptus Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Dana-Farber Cancer Institute Completes Deployment of MedAptus Infusion Services Module
2. Brooke Franchise Corporation Announces Selected July Results
3. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
4. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
5. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
6. Fry Construction Selected for High-Profile Medical Imaging Project
7. Meth Project Advertisements Selected for National Prevention Campaign
8. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
9. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
10. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
11. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...HINGTON, July 25 /PRNewswire/ -- Klafter & Olsen L...Care Corporation ("ArthroCare" or the,"Company") (... U.S. District,Court for the Western District of T...hased the common stock ArthroCare from January 24,...chaser Class Period") and all,persons or entities ...
(Date:7/25/2008)...ASANTON, Calif., July 25 /PRNewswire-FirstCall/ --...der in device-based mechanical,circulatory support...arts,today announced that it will report its oper... months of fiscal 2008 on Thursday, July 31., The...s financial,results and operating activities to al...
(Date:7/25/2008)...ROOK, Ill. July 25, 2008 The American Society f...idelines on the role of endoscopy in the bariatric... in the United States and the success in surgical ...er of weight-loss surgeries performed in the U.S.,...lines discuss endoscopy in the preoperative patien...
(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
...ron overdose during pregnancy could be harmful, ac...ften given to combat anemia in pregnancy but many...e the blood is unable to carry enough oxygen due t...ecause each red blood cell is unable to carry norm...
...he California Alliance for Inclusive Communities (...ed suicide and Assembly Bill 374. They join the ma...anizations already opposing assisted suicide. CAI... behalf of groups with developmental and other dis...
... new report released today by the Pharmaceutical R... that biopharmaceutical researchers are testing 27... death of Americans -- heart disease and stroke. ...cal trials or under review by the Food and Drug Ad...
...ith the advent of a possible new blockbuster drug ... of nicotine, alcohol, and drug addictions, global...nts are expected to rise from revenues of little o...on in 2010, according to Smoking Cessation and Add...
Other Medicine News:Health News:More Than 270 Medicines in Testing for Heart Disease and Stroke 2
(Date:7/23/2008)...uly 23 /- FluoroPharma Inc., a compan... for the Positron Emission Tomography,(PET) market...s novel,Fluorine-18 labeled tracer for myocardial ...cardiovascular product to complete Phase I clinica...igned to assess the blood flow in the,heart (myoca...
(Date:7/23/2008)...July 23 /- Dendreon Corpora...cts the Independent Data,Monitoring Committee (IDM...of overall survival relating to the Company,s Phas...oma Treatment, also known as D9902B) clinical tria...ompany,s investigational,active cellular immunothe...
(Date:7/22/2008)...efficacy results from a multi-center 293-patient E...ronto Stock Exchange Symbol: CYT, MONTREAL, July ...es,Inc., the global leader in cryotherapy products...t results previously presented from three,European...rctic Front(R),were published earlier today in th...
(Date:7/22/2008)...eting to Discuss Development Plan Completed Succes...tCall/ -- Amarin Corporation,plc (NASDAQ: AMRN ) ...,officials at the U.S. Food and Drug Administratio...AMR101 for the treatment of,hypertriglyceridemia. ...ding to Phase 3 with AMR101 in hypertriglyceridemi...
Breaking Medicine Technology:FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Polished to perfection 23702 1Polished to perfection 23702 2Zooming in on genetic shuffling 3984 1Zooming in on genetic shuffling 3984 2RNA emerges from DNAs shadow 3982 1RNA emerges from DNAs shadow 3982 2RNA emerges from DNAs shadow 3982 3James Briscoe awarded 2008 EMBO Gold Medal 3980 1James Briscoe awarded 2008 EMBO Gold Medal 3980 2James Briscoe awarded 2008 EMBO Gold Medal 3980 3
...nce of Recurrent Wheeze by,Almost Half, ABBOTT PAR...wswire-FirstCall/ -- Abbott and MedImmune today an...uly issue of Journal of,Pediatrics, showing that t...recurrent wheezing in premature infants by almost,...ure infants without,chronic lung disease who recei...
...Myeloma Workshop held in,Kos, Greece demonstrates ...h bortezomib, dexamethasone and lenalidomide plus,...y multiple,myeloma, and as a single agent in patie...obulinemia, NEW YORK, June 29, 2007 /PRNewswire-Fi...nnounced that 4 posters were,presented at the 11th...
Other Medicine Technology:New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7
...te Focus from Thermo Labsystems was designed speci...performance. Advanced features such as the new fa...n microvolumes help to define this as a new leader...le handle plate offers a custom fit for different ...
...igital offers improved ergonomics for today's exac...fied grippy finger rest and the large display wind...ipette Digitals also feature soft-touch tip ejecti....) and super blow-out for 0.2 - 50ul micro volume ...
...els cover the range from 2ul to 5000ul. Fills and...prevents inadvertent volume change. Novel hand gr...te is autoclavable at 121C(250F). To prevent corr...ble for one-handed operation. Auto or Normal trig...
...pettor is the #1 Pipettor for sub-microliter pipet...iability. Continuously adjustable. Features lPLUS,...ter. Easy interchangeable ejector buttons to fit l...ip ejector with three different lengths. Air-displ...
Medicine Products: